戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 ( left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                             New therapeutic approaches for castration-resistant prostate
2                                                             New therapeutic approaches for this disorder are needed.
3 es induced by type 1 interferon (IFN) cytokines could allow new therapeutic approaches for diseases in which these cytoki
4 could provide biomarkers for those whose tumors respond and new therapeutic approaches for those whose tumors do not.
5                  This knowledge can be useful for designing new therapeutic approaches for joint loss or for conditions a
6 his novel molecular pathway may prove valuable in designing new therapeutic approaches for modifying tumor cell growth an
7 ns to induce de novo cortical plasticity could help develop new therapeutic approaches for brain repair.
8 iogenic therapies, as well as small pilot studies exploring new therapeutic approaches for choroidal neovascularization.
9                                    There is a dire need for new therapeutic approaches for patients with poorly controlle
10 ain structure and function in Turner syndrome will generate new therapeutic approaches for this population.
11 might identify mechanisms of disease pathogenesis and guide new therapeutic approaches for disorders mediated by the immu
12                         This model might aid in identifying new therapeutic approaches for obesity and obesity-related di
13 development of selective inhibitors that might be useful in new therapeutic approaches for the treatment of cancer, neuro
14 rected therapy based on TFAP2C-regulated pathways to inform new therapeutic approaches for treatment of luminal breast ca
15 ects of T cell-depleting therapies and present inroads into new therapeutic approaches for treating diseases affecting th
16  of seed-targeting 8-mer LNA-antimiRs in the development of new therapeutic approaches for pharmacologic inhibition of di
17 entiated ES cells have the potential for the development of new therapeutic approaches for RPE-specific diseases such as
18 impediments to their use, thus requiring the development of new therapeutic approaches for safe and effective angiogenic
19 s of lung vascular leakage might lead to the development of new therapeutic approaches for the treatment of pulmonary oed
20 receptor CXCR2 are potential targets for the development of new therapeutic approaches for treatment of obesity-related i
21                      These findings support developments of new therapeutic approaches for chronic neurodegenerative diso
22 -mediated transformation and to investigate the efficacy of new therapeutic approaches for the treatment of human ALCL in
23 the community to assist in the discovery and translation of new therapeutic approaches for cancer.
24 mportant implications for organismal health and could offer new therapeutic approaches for neurodegenerative diseases and
25 merging subclones, which seed metastatic sites, might offer new therapeutic approaches for limiting tumour recurrence.
26                                 Altogether, these data open new therapeutic approaches for CGD-related inflammatory manif
27 derstanding the role of these proteins in muscle might open new therapeutic approaches for muscular dystrophies.
28 diomyopathy mutations at their sources, leading to possible new therapeutic approaches for these genetic diseases.
29 ulate cell-cycle progression, a number of which may provide new therapeutic approaches for the treatment of cancer.
30                             These discoveries have provided new therapeutic approaches for prevention and palliation of c
31 to the pathogenicity of a novel fusion oncogene and suggest new therapeutic approaches for a subset of glioblastomas.
32 lating both food intake and energy expenditure, and suggest new therapeutic approaches for obesity and its comorbidities.
33 nisms underlying appendage regeneration in mice and suggest new therapeutic approaches for regenerative medicine.
34 rucial for curtailing lethal immune activation, and suggest new therapeutic approaches for regulation of T-cell-mediated
35 which modulates TRAIL signaling in cancer cells and suggest new therapeutic approaches for TRAIL-resistant neoplasms.
36                                      These findings suggest new therapeutic approaches for alpha-synuclein induced neurod
37                           Furthermore, our work may suggest new therapeutic approaches for the treatment of congenital si
38 insight into toxin-mediated endothelial injury and suggests new therapeutic approaches for staphylococcal sepsis.
39                                       This insight suggests new therapeutic approaches for preventing diseases caused by
40                                                       These new therapeutic approaches for malignant gliomas are showing
41 will not only be of academic interest, but may also lead to new therapeutic approaches for individuals afflicted with thi
42 ogenic and drug-sensitive alterations may similarly lead to new therapeutic approaches for lung cancer.
43 esearch on this simple molluscan nervous system may lead to new therapeutic approaches for spinal cord injury, Fragile X
44 vation of adult globin expression could potentially lead to new therapeutic approaches for these hemoglobin disorders.
45 ghts into the pathogenesis of lung fibrosis and may lead to new therapeutic approaches for treating fibrotic lung disease
46 traffic in NPC cells by Rab9 overexpression and may lead to new therapeutic approaches for treatment of this disease.
47 l of GPCR trafficking in vivo and in some cases have led to new therapeutic approaches for treating human diseases that r
48                                                   Together, new therapeutic approaches for selectively targeting patholog
49 of COX-2, which provides a mechanistic basis for opening up new therapeutic approaches for protecting neurons from inflam
50 odel, manipulating this neuropeptidergic system might yield new therapeutic approaches for diet-induced obesity.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。